Clinical Trial Update: Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update for SGM-101 in colon, rectal, and pancreatic cancers, currently completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Colorectal Carcinoma
• Pancreatic Cancer
• Rectal Cancer

Drugs mentioned

• SGM-101

Snippet

Sponsor: Surgimab | Conditions: Colon Cancer, Rectum Cancer | Phase 1, Phase 2 | Status: COMPLETED